— Know what they know.
Not Investment Advice
Also trades as: GTMS.TO (TSX) · $vol 0M

GBNH NASDAQ

Greenbrook TMS Inc.
1W: +40.0% 1M: -61.6% 3M: -74.1% 1Y: -88.5% 3Y: -99.5%
$0.12
Last traded 2024-03-19 — delisted
NASDAQ · Healthcare · Medical - Care Facilities · $5.5M mcap · 13M float · 17.32% daily turnover

Balance Sheet Trends

Total Assets
$100M +38.3% ▲
5Y CAGR: +84.5%
Total Liabilities
$131M +133.8% ▲
5Y CAGR: +89.6%
Shareholders Equity
-$28M -263.6% ▼
Cash & Investments
$2M -84.8% ▼
5Y CAGR: +1.2%
Total Debt
$108M +140.7% ▲
5Y CAGR: +102.5%
Net Debt
$106M +211.6% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2018FY2019FY2020FY2021FY2022
— Assets —
Cash$9M$8M$19M$11M$2M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$9M$8M$19M$11M$2M
Net Receivables$7M$10M$11M$11M$14M
Inventory$0$0$0$1M$1M
Other Current Assets$2M$2M$1M$2M$3M
Total Current Assets$18M$20M$31M$25M$19M
Property, Plant & Equip.$911K$27M$28M$31M$56M
Goodwill & Intangibles$0$10M$9M$16M$26M
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$0$0$0
Total Non-Current Assets$911K$37M$38M$48M$81M
Total Assets$19M$57M$69M$73M$100M
— Liabilities —
Accounts Payable$2M$5M$7M$8M$17M
Short-Term Debt$179K$5M$6M$7M$14M
Deferred Revenue$0$0$177K$4M$0
Other Current Liabilities$2M$4M$14M$45K$7M
Total Current Liabilities$4M$13M$28M$19M$37M
Long-Term Debt$183K$21M$38M$38M$94M
Other Non-Current Liab.$0$0-$15M$0$0
Total Non-Current Liabilities$183K$21M$38M$38M$94M
Total Liabilities$4M$34M$66M$56M$131M
— Equity —
Common Stock$27M$50M$60M$98M$114M
Retained Earnings-$15M-$30M-$60M-$85M-$147M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity$14M$23M$3M$17M-$28M
Total Liabilities & Equity$19M$57M$69M$73M$100M
— Key Metrics —
Total Debt$362K$26M$44M$45M$108M
Net Debt-$9M$18M$25M$34M$106M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms